Is a bolus insulin injection used in the management of Diabetic Ketoacidosis (DKA)?

Insulin Bolus in Diabetic Ketoacidosis Management

For adult patients with diabetic ketoacidosis (DKA), an intravenous bolus of regular insulin at 0.15 units/kg body weight is recommended before starting the continuous insulin infusion, provided that hypokalemia (K+ < 3.3 mEq/L) is excluded. 1

Adult DKA Management Protocol

Initial Insulin Administration

• For adult patients with moderate to severe DKA, administer an intravenous bolus of regular insulin at 0.15 units/kg body weight, followed by a continuous infusion of regular insulin at 0.1 unit/kg/hour (typically 5-7 units/hour in adults) 1
• The bolus dose should only be given after confirming serum potassium is ≥3.3 mEq/L to prevent potentially dangerous hypokalemia 1, 2
• The continuous insulin infusion should be maintained until resolution of ketoacidosis (pH >7.3, serum bicarbonate ≥18 mEq/L, and anion gap ≤12 mEq/L) regardless of glucose levels 2, 3

Monitoring and Adjustment

• If plasma glucose does not fall by 50 mg/dL from the initial value in the first hour, check hydration status; if acceptable, double the insulin infusion rate every hour until achieving a steady glucose decline of 50-75 mg/hour 1
• When serum glucose reaches 250 mg/dL, add 5% dextrose to intravenous fluids while continuing insulin therapy to resolve ketosis 2, 3
• Monitor blood glucose every 1-2 hours and electrolytes every 2-4 hours 2, 3

Special Considerations

Pediatric Patients

• An initial insulin bolus is NOT recommended for pediatric patients with DKA 1
• For children, start directly with a continuous insulin infusion at 0.1 unit/kg/hour without a bolus dose 1, 2

Mild DKA

• For mild DKA cases, regular insulin may be given subcutaneously or intramuscularly instead of intravenously 1
• In mild cases, start with a "priming" dose of regular insulin of 0.4-0.6 units/kg body weight, half as an intravenous bolus and half as a subcutaneous or intramuscular injection 1

Evidence Considerations

Benefits of Bolus Insulin

• The low-dose insulin regimen (bolus followed by continuous infusion) decreases plasma glucose concentration at a rate of 50-75 mg/dL/hour, similar to higher-dose insulin regimens 1
• The bolus helps to rapidly achieve therapeutic insulin levels in the bloodstream 1

Potential Risks

• Recent research suggests that an insulin bolus prior to continuous infusion may be associated with more adverse effects, particularly hypokalemia, without significant benefits in DKA resolution time 4
• Some studies have found no significant differences in the rate of change of glucose or anion gap between patients who received a bolus and those who did not 5

Important Caveats

• Never interrupt insulin infusion when glucose levels fall; instead, add dextrose to prevent hypoglycemia while continuing insulin to clear ketosis 3
• Ketonemia typically takes longer to clear than hyperglycemia, so insulin therapy must continue until ketoacidosis resolves, even if blood glucose normalizes 1
• Direct measurement of β-hydroxybutyrate in blood is the preferred method for monitoring DKA resolution, as the nitroprusside method only measures acetoacetic acid and acetone 1, 2
• When transitioning to subcutaneous insulin, administer basal insulin 2-4 hours before stopping the intravenous insulin to prevent recurrence of ketoacidosis 2, 3